Coinbase
COIN
Microsoft
MSFT
Salesforce
CRM
4
Meta Platforms
META
5
Amazon
AMZN
US Stock MarketDetailed Quotes
DNLI Denali Therapeutics
- 14.235
- -0.715-4.78%
Trading Mar 11 10:39 ET
2.07BMarket Cap-5.54P/E (TTM)
14.950High14.230Low204.36KVolume14.950Open14.950Pre Close2.96MTurnover0.16%Turnover RatioLossP/E (Static)145.22MShares33.33052wk High1.68P/B1.87BFloat Cap14.01052wk Low--Dividend TTM131.34MShs Float93.940Historical High--Div YieldTTM4.82%Amplitude12.320Historical Low14.504Avg Price1Lot Size
Denali Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 2.88%-347.69M | 15.15%-83.72M | 32.31%-59.14M | 19.39%-91.22M | -93.22%-113.62M | -46.29%-357.99M | -35.77%-98.66M | -53.14%-87.36M | -163.81%-113.17M | 18.45%-58.8M |
| Net income from continuing operations | -191.12%-422.77M | 3.95%-114.75M | -7.89%-107.19M | -154.00%-99.03M | 7.27%-101.8M | 55.45%-145.22M | -21.07%-119.47M | 3.82%-99.35M | 411.91%183.38M | -68.32%-109.78M |
| Operating gains losses | ---14.54M | --0 | --0 | --0 | ---14.54M | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -46.24%8.99M | 20.30%2.62M | 2.35%2.27M | -15.01%1.94M | -78.48%2.16M | 61.09%16.73M | -46.79%2.18M | 3.55%2.22M | 10.28%2.29M | 383.26%10.05M |
| Other non cash items | -9.60%-4.07M | -9.84%-1.05M | -9.61%-1.05M | -9.81%-1.02M | -9.12%-957K | -13.05%-3.72M | -12.22%-955K | -16.85%-957K | -11.14%-928K | -12.01%-877K |
| Change In working capital | 105.84%16.94M | 80.46%10.56M | 788.70%30.35M | 97.39%-8.16M | -173.27%-15.81M | -1,106.52%-289.93M | 792.98%5.85M | -120.95%-4.41M | -3,103.79%-312.95M | 160.01%21.58M |
| -Change in prepaid assets | 39.42%-2.48M | 102.42%145K | 20,257.47%17.71M | -143.47%-1.57M | -948.97%-18.77M | -48.33%-4.09M | -336.97%-6M | -99.35%87K | 122.58%3.61M | -244.04%-1.79M |
| -Change in payables and accrued expense | 270.43%18.81M | 2.79%12.57M | 406.08%9.87M | 75.98%-6.59M | -87.43%2.96M | -61.50%5.08M | 429.07%12.23M | -128.72%-3.23M | -509.23%-27.44M | 433.07%23.51M |
| -Change in other current assets | --603K | --1.78M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| -Change in other current liabilities | --0 | ---- | ---- | ---- | ---- | ---379K | ---- | ---- | ---- | ---- |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | -743.05%-290.53M | --0 | 64.37%-1.27M | -60,259.71%-289.12M | 99.53%-141K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 2.88%-347.69M | 15.15%-83.72M | 32.31%-59.14M | 19.39%-91.22M | -93.22%-113.62M | -46.29%-357.99M | -35.77%-98.66M | -53.14%-87.36M | -163.81%-113.17M | 18.45%-58.8M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -135.60%-88.76M | 135.75%172.21M | -7.19%93.66M | -41.35%98.57M | -388.80%-453.19M | 276.33%249.31M | 157.27%73.05M | 554.45%100.91M | 89.63%168.07M | 21.35%-92.72M |
| Net PPE purchase and sale | -22.98%-15.91M | -127.83%-5.09M | -87.81%-3.88M | 18.19%-4.79M | 22.83%-2.15M | 27.44%-12.94M | 53.91%-2.24M | 65.82%-2.07M | -102.21%-5.85M | 31.06%-2.79M |
| Net investment purchase and sale | -127.78%-72.84M | 135.51%177.3M | -5.28%97.54M | -40.57%103.36M | -401.55%-451.04M | 312.25%262.25M | 161.35%75.28M | 379.65%102.98M | 90.02%173.92M | 21.00%-89.93M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -135.60%-88.76M | 135.75%172.21M | -7.19%93.66M | -41.35%98.57M | -388.80%-453.19M | 276.33%249.31M | 157.27%73.05M | 554.45%100.91M | 89.63%168.07M | 21.35%-92.72M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2,617.76%484.3M | -188.59%-4.17M | -844.74%-18.56M | -25.09%6.76M | 31,089.21%500.28M | -94.26%17.82M | -98.43%4.71M | -51.65%2.49M | 104.88%9.02M | 9.64%1.6M |
| Net issuance payments of debt | ---32.34M | ---8.32M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net common stock issuance | --499.25M | --0 | --0 | --0 | --499.25M | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | -2.42%17.39M | -11.69%4.16M | 118.94%5.46M | -25.09%6.76M | -36.28%1.02M | 23.28%17.82M | 36.93%4.71M | -51.65%2.49M | 104.88%9.02M | 9.64%1.6M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2,617.76%484.3M | -188.59%-4.17M | -844.74%-18.56M | -25.09%6.76M | 31,089.21%500.28M | -94.26%17.82M | -98.43%4.71M | -51.65%2.49M | 104.88%9.02M | 9.64%1.6M |
| Net cash flow | ||||||||||
| Beginning cash position | -41.39%128.68M | -38.36%92.21M | -42.90%76.25M | -10.75%62.15M | -41.39%128.68M | -25.57%219.54M | 24.54%149.59M | -14.71%133.55M | -34.59%69.63M | -25.57%219.54M |
| Current changes in cash | 152.67%47.85M | 503.37%84.32M | -0.51%15.96M | -77.93%14.11M | 55.62%-66.53M | -20.46%-90.86M | -121.03%-20.91M | 143.97%16.04M | 27.49%63.92M | 20.48%-149.91M |
| End cash Position | 37.19%176.54M | 37.19%176.54M | -38.36%92.21M | -42.90%76.25M | -10.75%62.15M | -41.39%128.68M | -41.39%128.68M | 24.54%149.59M | -14.71%133.55M | -34.59%69.63M |
| Free cash flow | 1.97%-363.61M | 11.98%-88.81M | 29.53%-63.02M | 19.34%-96.01M | -87.97%-115.77M | -41.28%-370.93M | -30.16%-100.89M | -41.74%-89.43M | -159.92%-119.02M | 19.12%-61.59M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025